InvestorsHub Logo
Followers 17
Posts 642
Boards Moderated 0
Alias Born 02/27/2008

Re: beambe post# 5040

Wednesday, 01/06/2016 9:47:28 AM

Wednesday, January 06, 2016 9:47:28 AM

Post# of 5644
Of course we can fall below 1.20. We have the JP Morgan Healthcare conference starting on Jan 11 in San Francisco. It's the biggest one of the year and you would think that there is going to be some volatility going into it. There always is. Plus after EyeGuard B, do you really think Xoma is going to say or indicate anything to go back on the radar of the scum attorneys who are always circling like sharks? They have learned their lessons well. Try contacting IR and getting anything but the most vanilla of responses. I have said before that they have totally changed their business acumen in response to history. Expect tight lipped and very matter of fact updates and trial results that should remind you of say, Novartis? It all bodes well going forward in my view. Job one, move from development into commercialization so real consistent earnings become the norm.

You want to buy cheaper? You'll get your chance until trial results are made public.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XOMA News